IceCure Medical (ICCM) Liabilities and Shareholders Equity (2020 - 2026)

IceCure Medical (ICCM) has 7 years of Liabilities and Shareholders Equity data on file, last reported at $13.3 million in Q1 2026.

• On a quarterly basis, Liabilities and Shareholders Equity rose 19.8% year-over-year to $13.3 million in Q1 2026; TTM through Mar 2026 was $52.9 million, a 2.69% decrease from a year earlier, with the FY2025 full-year figure at $13.9 million, up 10.43% from the prior year.
• Liabilities and Shareholders Equity for Q1 2026 stood at $13.3 million, down from $13.9 million in the prior quarter.
• Over the last five years, Liabilities and Shareholders Equity for ICCM reached as high as $30.2 million in Q4 2022 and fell as low as $10.6 million in Q2 2025.
• Historically, Liabilities and Shareholders Equity has averaged $18.3 million across 5 years, with a median of $16.1 million in 2024.
• Across the five-year window, Liabilities and Shareholders Equity tumbled 45.64% in 2023 and rose 19.8% in 2026, its largest moves.
• Year by year, Liabilities and Shareholders Equity stood at $30.2 million in 2022, then slumped by 45.64% to $16.4 million in 2023, then decreased by 23.36% to $12.6 million in 2024, then increased by 10.43% to $13.9 million in 2025, then decreased by 4.21% to $13.3 million in 2026.
• Per Business Quant data, the three most recent Liabilities and Shareholders Equity figures were $13.3 million in Q1 2026, $13.9 million in Q4 2025, and $15.1 million in Q3 2025.